Insilico Medicine Nominates Preclinical Candidate of Inhalation Solution for ISM001-055, the First Generative AI IPF Drug
Insilico Medicine merges nebulizer device with AI-driven drug discovery; Potential advantages for the inhalation solution include a smaller effective dose, larger safety window and reduced side effects; As demonstrated in preclinical studies, the...
Solar Energy Storage System EP Cube Cooperates with Treedom to Boost Environmental-friendly and Sustainable Development
SAN FRANCISCO, July 22, 2023 /PRNewswire/ -- EP Cube announced its partnership with Treedom, the first platform in the world allowing customers to plant a tree remotely and track the story online, and jointly launched the "One Move to Green, One...
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
SHANGHAI, July 22, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 7MW3711 for advanced malignant solid tumor was approved by the National...
WiMi Developed an HMD-based Control System for Humanoid Robots Controlled by BCI
BEIJING, July 21, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced its development of a humanoid robot control system...
JSAUX'S STEAM DECK RGB DOCKING STATION & RGB BACKPLATE ARE NOW AVAILABLE
The electronics brand celebrates its 7th anniversary during July HONG KONG, July 21, 2023 /PRNewswire/ -- Electronics brand JSAUX is celebrating its seventh anniversary during July and it has announced a new batch of Steam Deck accessories: the RGB...
Jeffrey Triganza Joins Vantage Markets Australia as Head of Market Analysis
SYDNEY, July 21, 2023 /PRNewswire/ -- Vantage Markets, an award-winning multi-asset broker for Contracts for Difference (CFDs), has today announced the appointment of Jeffrey Triganza as the new Head of Market Analysis for Australia. Drawing on his...
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer
SEONGNAM, South Korea, July 21, 2023 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on July 19 that the US FDA had granted an orphan drug designation for small cell lung cancer for SNB-101 (API: SN-38), a new polymer...
REALTY ONE GROUP NAMED TOP GLOBAL FRANCHISE
The UNBrokerage, with its ONE-of-a-Kind Brand and COOLTURE, Once Again Makes Entrepreneur's Prominent Top 200 Global Franchise Brands 2023 LAS VEGAS, July 21, 2023 /PRNewswire/ -- Realty ONE Group, a modern, purpose-driven lifestyle brand and ONE of...